Antidotes to non-vitamin K oral anticoagulants: necessary or not?
about
Edoxaban in venous thromboembolism and stroke prevention: an appraisalNew oral anticoagulant prescription rate and risk of bleeding in an Italian region.Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice.Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
P2860
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@en
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@nl
type
label
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@en
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@nl
prefLabel
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@en
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@nl
P2860
P1476
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
@en
P2860
P304
P356
10.1517/14656566.2015.1057119
P407
P577
2015-06-16T00:00:00Z